Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients...
Transcript of Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients...
![Page 1: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/1.jpg)
Dealing with Cognitive Impairment in the Patient with Breast Cancer
Tim A. Ahles, Ph.D.
Department of Psychiatry and Behavioral Sciences
Neurocognitive Research Lab
![Page 2: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/2.jpg)
Sources of Funding
• Office of Cancer Survivorship, National Cancer Institute (CA23108, CA87845, CA116394)
• Chanel Foundation
• Martel Foundation
• Starr Consortium
![Page 3: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/3.jpg)
Cognitive Impact of Cancer Therapies
• Cranial radiation +/- intrathecal chemo• Cranial surgery• Biological response modifiers• High-dose chemotherapy• Standard-dose chemotherapy• Hormonal Therapies
![Page 4: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/4.jpg)
Common Cognitive Problems Reported Post-Treatment
• Memory and Concentration
• Executive Function
• Ability to Learn New Material /Reading Comprehension
• Ability to Work with Numbers
![Page 5: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/5.jpg)
Pattern of Cognitive Problems
• Not everyone is affected (15-20%)
• Problems may come and go (Good and bad days
• Often worse when:
- Multitasking
- Under stress or deadline pressure
- Fatigued / Poor sleep
![Page 6: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/6.jpg)
Factors Affecting Cognitive Functioning
• Fatigue / Sleep disorders
• Depression, anxiety, stress
• Pain and pain medications
• Other physical illnesses
![Page 7: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/7.jpg)
Results of Post-treatment Studies
• Poorer cognitive performance for survivors treated with chemotherapy evaluated 6 months to 10 years post-treatment compared to survivors not exposed to chemotherapy
• Only a subgroup of survivors (17-35%) experienced persistent cognitive problems
• Cognitive problems not explained by depression, anxiety, or fatigue
![Page 8: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/8.jpg)
Adjusted z-Transformed Domain Scores for the Chemotherapy vs. Local Therapy Groups
-0.3
-0.2
-0.1
0
0.1
0.2
0.3
0.4
VerbalAbility
VerbalLearning
VerbalMemory*
VisualMemory
Psycho-motor*
Motor Attention/Correct
Attention/RT
SpatialAbility
Neuropsychological Domain
Local TherapyChemotherapy
*p<.05, adjusted for age and education
![Page 9: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/9.jpg)
Results of Longitudinal Studies
• 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment which is not related to depression, anxiety or fatigue
• Patients treated with chemotherapy and patients treated with non-chemotherapy-based regimens performed more poorly than matched healthy controls
![Page 10: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/10.jpg)
Follow-up Time Period
Adju
sted
Glo
bal S
core
BA PT 6M 18M
-1.0
-0.5
0.0
0.5
1.0
Global(Adjusted for age and education)
ControlLocalChemo
Follow-up Time Period
Adju
sted
Glo
bal S
core
BA PT 6M 18M
-0.2
0.0
0.2
0.4
0.6
Global(Adjusted for age, education, and baseline)
ControlChemoLocal
![Page 11: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/11.jpg)
Processing Speed: Change Scores from Baseline
-0.1-0.05
00.05
0.10.15
0.20.25
0.30.35
1 Month 6 Months 18Months
Low PerformanceNormal PerformanceControls
![Page 12: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/12.jpg)
Potential Explanations for Pretreatment Differences
• Shared risk factors for development of cancer and mild cognitive decline
• Potential role of DNA damage and the genetics of DNA repair
![Page 13: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/13.jpg)
DNA Damage Hypothesis
• DNA damage is associated with risk for cancer and risk for neurodegenerative disorders / cognitive changes with aging
• Chemotherapy, as well as other aspects of cancer treatments, are DNA damaging
![Page 14: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/14.jpg)
![Page 15: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/15.jpg)
Potential Explanations for Post-Treatment Results
• Potential role of endocrine treatments (Tamoxifen and Aromatase Inhibitors)
• Role of chemotherapy-induced menopause
• Estrogen reduction may be associated with cognitive change
![Page 16: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/16.jpg)
Renaming “Chemobrain”
• Cancer or cancer-associated cognitive change
• “if you have Tim's e-mail address, maybe contact him and say if he expects his favorite project to resonate with the general public, he'd better leave the name as is because "chemobrain" slips off the tongue quite willingly, while the proposed new name is a gnarly mouthful!”
![Page 17: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/17.jpg)
Neuropsychological Testing
• Primarily designed to assess people with significant brain damage (stroke, head injury) or disease (Alzheimer’s)
• Problem: Many cancer survivors score well within the normal range even though they report having cognitive problems
![Page 18: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/18.jpg)
Results of MRI, PET and EEG Studies
• MRI and PET studies suggest that there are changes in brain structure and function associated with chemotherapy
• EEG studies suggest changes in measures of information processing (P300) associated with chemotherapy
![Page 19: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/19.jpg)
fMRI Activation Pattern for Identical Twins Discordant for Breast Cancer
![Page 20: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/20.jpg)
Genetic Factors
• Repair of nerves and blood vessels (APOE)
• DNA repair
• Inflammatory response
• Blood brain barrier
• Understanding genetic risk factors may lead to tailored treatments which avoid toxicities like cognitive problems
![Page 21: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/21.jpg)
Interventions
• Pharmacologic Interventions psychostimulants cholinesterase inhibitorsgingko biloba
• Cognitive Rehabilitation
![Page 22: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/22.jpg)
Memo ry a nd A ttention Training:
A Br ief Behavi oral Ski lls Pr og ram fo r Can cer S urvivors
with Atte ntion and Memo ry P roble ms Ass ociat ed with
Che mothe rapy
Robe rt J. Fer guson, Ph.D.*
Beha vioral Me dicin e Section
Dar tmout h Med ica l School
RUNN ING HEAD : Memor y and Atten tion T raining
*This i s not a publis hed documen t. P lease do no t reproduce or dis tribute wit hout
permissi on of the aut hor.
![Page 23: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/23.jpg)
Memory and Attention Training
• Education
--Common cognitive errors
--Different types of memory and attention
![Page 24: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/24.jpg)
Memory and Attention Training
• Compensatory Strategies
--Lists, calendars, palm pilots
--Self-instructional training
--Scheduling / Time management
--Sleep hygiene / Fatigue management
![Page 25: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/25.jpg)
Memory and Attention Training
• Relaxation Training
--Progressive Muscle Relaxation
--Breathing exercises
![Page 26: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/26.jpg)
Memory and Attention Training
• Problem-Solving
--A structured approach to applying the skills in everyday life
![Page 27: Dealing with Cognitive Impairment in the Patient with ... · • 20-30% of breast cancer patients demonstrate lower than expected cognitive performance prior to adjuvant treatment](https://reader036.fdocuments.us/reader036/viewer/2022070110/6048b87af91f4960e35bea24/html5/thumbnails/27.jpg)
Summary• Cognitive problems experienced by cancer patients are
likely not exclusively associated with chemotherapy
• Pretreatment cognitive problems suggest that there may be common risk factors for development of cancer and cognitive problems
• Imaging techniques will be important to understanding cognitive changes associated with breast cancer treatments
• Genetic factors are likely important in increasing vulnerability for long-term cognitive problems
• Medication and cognitive rehabilitation interventions are being evaluated